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Childhood kidney disease is associated with increased risk of 
end-stage renal failure in adulthood 
         
STUDY DESIGN 
Design: Cohort study  
   
STUDY QUESTION 
Setting: Israel 
 
Patients: 1.5 million young people (aged 16-25) examined prior 
to military service between 1967 and 1997. 
 
Exposure: Any history of childhood kidney disease, including 
structural anomalies and pyelonephritis.  
 
Outcomes: Development of end-stage renal failure in adulthood. 
 
Follow-up period: 30 years from initial examination. 
 
Patient follow-up: Inclusion on the Israeli end-stage renal 
failure disease registry. 
 
MAIN RESULTS:  
The study results are summarised in table 1 below. 
History of 
childhood renal 
disease 
Unadjusted HR 
(95% CI) 
Adjusted HR (95 
CI)* 
Adjusted HR (95 
CI)** 
Nil Reference - - 
Congenital 
renal/urinary 
tract anomaly 
6.07 (4.04-9.12) 5.47 (3.63-8.24) 5.19 (3.41-7.90) 
Pyelonephritis 3.80 (2.94-4.76) 3.74 (2.94-4.76) 4.03 (3.16-5.14) 
Glomerulonephritis 3.91(2.83-5.41) 3.84 (2.78-5.31) 3.85 (2.77-5.36) 
Any renal disease 4.04 (3.49-4.93) 4.04 (3.40-4.81) 4.19 (3.52-4.99) 
Table 1: Risks of adult end-stage renal disease based on history of childhood renal 
GLVHDVHDGMXVWHGIRUDJHDQGVH[DGMXVWHGIRUDJHVH[IDWKHU¶Vplace of birth, 
period of enrolment, body mass index and systolic blood pressure 
 
CONCLUSION: A history of childhood renal disease, even if 
there is no evidence of renal impairment in adolescence, is 
associated with significantly increased risk of end-stage 
renal failure in adulthood. 
 
ABSTRACTED FROM: Calderon-Margalit, R., Golan, E., Twig, G., 
Leiba, A., Tzur, D., Afek, A., Skorecki, K. and Vivante, A., 
2018. History of Childhood Kidney Disease and Risk of Adult 
End-Stage Renal Disease. New England Journal of Medicine, 
378(5), pp.428-438. 
 Abstracted by Amanda J Friend, Leeds Institute of Cancer and 
Pathology, University of Leeds School of Medicine, Leeds, UK 
Amanda.friend@nhs.net 
 
 
How important is a history of kidney disease in childhood if 
at the age of 16 you have no proteinuria, a normal blood 
pressure (BP) and serum creatinine? This cohort study by 
Calderon-Margalit et al suggests it is more important than 
previously recognised, as you are still 4 times more likely to 
progress to end stage renal failure (ESRF) before the age of 
40. This may leave some of us feeling uncomfortable about 
those we have transferred from our services; did we give 
explicit advice about follow up or did we falsely reassure 
that all would be ok?  
This large historical database is limited by an information 
gap between renal function at age 16 and the age of 
development of ESRF, with no data provided about additional 
risk factors between these time points. It cannot help inform 
the decision regarding frequency of monitoring, what this 
should include, and the appropriate thresholds for treatment 
initiation. As evidence shows that early detection and 
proactive management of hypertension and proteinuria can slow 
the progression to ESRF in those with CKD1this would have been 
a useful endpoint to have been included. 
The pragmatic approach at present would be annual surveillance 
of BP and urinalysis via primary care on transition from 
paediatric to adult services. However, many healthcare systems 
are not yet sophisticated enough to ensure this would occur, 
thus patient information and empowerment are essential. These 
patients will often have been too young to remember their 
initial presentation and robust transition processes are 
required to ensure the patient has the opportunity to discuss 
their past medical history and the potential consequences for 
their future health, including the role of annual 
surveillance. 
In time, as our understanding of the genetics of renal disease 
and the use of renal registry data increases our understanding 
of disease sub-groups it could allow a rationalisation to this 
surveillance. However, the converse is more likely with an 
expanding number of children needing surveillance to include 
those born prematurely, with low birth weight or who suffer an 
acute kidney injury on the basis of the Brenner 
hyperfiltration hypothesis2 where total nephron mass is 
important.  
1. Fogo, A.B. Pediatr Nephrol (2007) 22: 2011.  
2. Brenner BM et al.The hyperfiltration theory: a paradigm 
shift in nephrology, Kidney Int,1996,vol.49(pg.1774-1777) 
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